These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
906 related articles for article (PubMed ID: 28384112)
1. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy. Dourmishev LA Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112 [TBL] [Abstract][Full Text] [Related]
2. High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies. Bae SS; Lee YY; Shahbazian A; Wang J; Meriwether D; Golub I; Oganesian B; Dowd T; Reddy ST; Charles-Schoeman C Rheumatology (Oxford); 2020 Nov; 59(11):3515-3525. PubMed ID: 32830270 [TBL] [Abstract][Full Text] [Related]
3. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre. Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878 [TBL] [Abstract][Full Text] [Related]
4. Corticosteroids in Myositis and Scleroderma. Postolova A; Chen JK; Chung L Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554 [TBL] [Abstract][Full Text] [Related]
5. Classification, diagnosis, and management of idiopathic inflammatory myopathies. Lazarou IN; Guerne PA J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis). Pongratz D J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory myopathies: evaluation and management. Greenberg SA Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of inflammatory and autoimmune myopathies. Dalakas MC Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Dalakas MC Neuromuscul Disord; 2006 Apr; 16(4):223-36. PubMed ID: 16542836 [No Abstract] [Full Text] [Related]
11. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379 [TBL] [Abstract][Full Text] [Related]
12. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis]. Váncsa A; Dankó K Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067 [TBL] [Abstract][Full Text] [Related]
13. Current Classification and Management of Inflammatory Myopathies. Schmidt J J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091 [TBL] [Abstract][Full Text] [Related]
14. [Idiopathic inflammatory myopathies. A review]. Acosta I; Matamala JM; Jara P; Pino F; Gallardo A; Verdugo R Rev Med Chil; 2019 Mar; 147(3):342-355. PubMed ID: 31344172 [TBL] [Abstract][Full Text] [Related]
15. [Current therapy for polymyositis and dermatomyositis]. Chérin P Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983 [TBL] [Abstract][Full Text] [Related]